MDACC Study No:2007-0870 ( NCT No: NCT02357992)
Title:STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy
Principal Investigator:Jack Roth
Treatment Agent:Radiation
Study Status:Open
Study Description:Unavailable
Hide details for General InformationGeneral Information

Disease Group:Lung
Phase of Study:N/A
Treatment Agents:Radiation
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:There will be 3 - 4 clinic visits over 3 - 10 days for the treatment.
Supported By:Varian
Return Visit:Every 6 months for 2 years then yearly for 3 years
Home Care:None

Hide details for Study Contact InformationStudy Contact Information

Physician Name:Jack Roth
Dept:Thoracic & Cardiovascular
For Clinical Trial Enrollment:713-563-9152
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults